A Team Dedicated to Building Collaborations and Partnerships
Strategic collaborations and partnerships have been an important part of our development and growth as a biopharmaceutical company. The following graphic illustrates our development and commercialization strategy in human health:

We are currently looking for partnership opportunities for certain novel small-molecule therapeutics derived from our boron chemistry platform in the following areas:

• Dermatology: We are currently seeking commercial partnership and R&D collaboration opportunities for our dermatology portfolio which includes products in preclinical and clinical development for psoriasis, tinea pedis, acne and atopic dermatitis.
• Autoimmune/Inflammation/Respiratory: We are currently seeking commercial partnership and R&D collaboration opportunities for systemic applications of our anti-inflammatory compounds based on our boron chemistry platform.
• Non-core therapeutic areas. We believe boron chemistry has utility in a broad range of diseases outside of our core therapeutic areas. To maximize the value of our boron chemistry platform and to provide non-dilutive capital to support development in our core therapeutic areas, we have entered into and will continue to seek partnerships early in development for compounds in non-core areas, such as parasitic, cancer and ophthalmic indications and for applications in animal health.

Strategic Alliances

Partnering Opportunities
For more information about business development opportunities, please contact the Business Development Department.

Email
busdev@anacor.com

Mail
Anacor Pharmaceuticals, Inc.
Attn: Business Development Department
1020 East Meadow Circle
Palo Alto, CA 94303